GlassScriptPhysician profile
Matthew Mccourt
NPI 1326780107
$2,987.66
in general payments reported to CMS, 2019-2025
11 companies · $623 in 2025
The $623 reported for 2025 was more than what 82% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $173 · 2023: $727 · 2024: $1,464 · 2025: $623.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,741 · Travel and Lodging: $1,055 · Entertainment: $17.66.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,741.21 |
| Travel and Lodging | $1,055.33 |
| Entertainment | $17.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,746.25 | 2023-2025 | Dailies, Precision 1, Precision7 |
| Johnson & Johnson Vision Care, INC. | $317.84 | 2022-2025 | Acuvue |
| Tarsus Pharmaceuticals, INC. | $275.76 | 2025 | Xdemvy |
| Glaukos Corporation | $198.65 | 2023 | |
| Oyster Point Pharma, INC. | $148.51 | 2023 | Tyrvaya |
| Sun Pharmaceutical Industries INC. | $124.98 | 2022 | |
| Bausch & Lomb Americas INC. | $99.68 | 2023 | Miebo |
| Sight Sciences, INC. | $21.80 | 2023 | Tearcare System |
| Coopervision INC. | $18.67 | 2023 | Misight Contact Lens |
| Thea Pharma INC. | $17.86 | 2022 | |
| Optos, INC. | $17.66 | 2023 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Mccourt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.